Biocon Limited
BIOCON
株式のランク
#3392
Biocon Limited functions as a biopharmaceutical firm, engaged in the production... Biocon Limited functions as a biopharmaceutical firm, engaged in the production of pharmaceutical, medicinal chemical, and plant-derived products. Its business activities are organized into distinct segments: Generics, Novel Biologics, Biosimilars, and Research Services. The company dedicates its efforts to crucial therapeutic domains, including diabetes, oncology, immunology, ophthalmology, and bone health disorders. Furthermore, Biocon provides comprehensive services encompassing the discovery, development, and manufacturing of both small and large molecules. With a wide international presence, it caters to customers in roughly 120 nations. Headquartered in Bengaluru, India, Biocon Limited commenced operations in 1978.
株価
$3.75
最終同期: 2026-10-19
時価総額
$5.13B
変化（1日）
-2.30%
変化（1年）
-9.49%
国
IN
取引 Biocon Limited (BIOCON)
カテゴリー
Healthcare
Biocon Limited（BIOCON）の配当利回りの履歴
Biocon Limited（銘柄コード: BIOCON）の配当利回り（TTM）は2024-03-31時点で0.63%です。
過去5年間の平均配当利回り: 0.22%
過去5年間の平均配当利回り: 0.22%
Biocon Limited（BIOCON）の2004から2026までの配当利回りの履歴
各年末時点の配当利回り（TTM）
| 年 | 配当利回り | 変化 |
|---|---|---|
| 2026 (TTM) | 0.14% | -30.00% |
| 2025 | 0.20% | -68.25% |
| 2024 | 0.63% | 117.24% |
| 2023 | 0.29% | 0.00% |
| 2022 | 0.00% | 0.00% |
| 2021 | 0.00% | -100.00% |
| 2020 | 0.22% | 0.00% |
| 2019 | 0.22% | 0.00% |
| 2018 | 0.22% | 0.00% |
| 2017 | 0.00% | -100.00% |
| 2016 | 2.22% | 73.44% |
| 2015 | 1.28% | -28.89% |
| 2014 | 1.80% | 1.12% |
| 2013 | 1.78% | -7.29% |
| 2012 | 1.92% | 84.62% |
| 2011 | 1.04% | -3.70% |
| 2010 | 1.08% | -40.33% |
| 2009 | 1.81% | 151.39% |
| 2008 | 0.72% | 35.85% |
| 2007 | 0.53% | 12.77% |
| 2006 | 0.47% | 88.00% |
| 2005 | 0.25% | 0.00% |
| 2004 | 0.00% | 0.00% |
類似企業または競合他社の配当利回り（TTM）
| 企業 | 配当利回り | 国 |
|---|---|---|
| 0.00% |
US
|
|
| 0.00% |
US
|
|
| 2.17% |
AU
|
|
| 0.00% |
CH
|
|
| 0.00% |
NL
|
